BOWMED LIMITED

05036443
Dissolved London

Manufacture of basic pharmaceutical products

0 employees website.com
Life sciences and medical technology Manufacture of basic pharmaceutical products
B

BOWMED LIMITED

05036443

Manufacture of basic pharmaceutical products

Founded 6 Feb 2004 Dissolved London, United Kingdom 0 employees website.com
Life sciences and medical technology Manufacture of basic pharmaceutical products
Accounts Submitted 19 Jan 2023
Confirmation Submitted 10 Feb 2023 Next due 20 Feb 2024 29 months overdue
Net assets £0
Total assets £0
Total Liabilities £0
Charges None No charges registered

Contact & Details

Contact

Registered Address

30 Finsbury Square London EC2A 1AG

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for BOWMED LIMITED (05036443), a dissolved life sciences and medical technology company based in London, United Kingdom. Incorporated 6 Feb 2004. Manufacture of basic pharmaceutical products. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2022
Type dormant
Next accounts
Due by

Balance Sheet & P&L (2013–2022)

Cash in Bank

N/A

Net Assets

N/A

Total Liabilities

N/A

Turnover

N/A

Employees

N/A

Debt Ratio

N/A

Financial History

Revenue, profit, EBITDA and key financial figures

2022
31 Dec Year End
2021
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

2 Allotments 1,933,633 Shares £1.93m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
18 Jun 20201,933,632£1.93m£1
18 Jun 20201£1.18£1.18

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (2)

Teva Pharma Holdings Limited
100.0%
1,933,833
Arrow Group Aps
0.0%
0

Persons with Significant Control

Persons with Significant Control (1)

1 Active 1 Ceased
Active
Notified 11 Mar 2022
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Arrow Group Aps

Ceased 11 Mar 2022

Ceased

Group Structure

Group Structure

BOWMED LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
2 Dec 2024GazetteGazette Dissolved Liquidation
2 Sept 2024InsolvencyLiquidation Voluntary Members Return Of Final Meeting
7 Dec 2023AddressChange Sail Address Company With New Address
15 Nov 2023InsolvencyLiquidation Voluntary Appointment Of Liquidator
15 Nov 2023InsolvencyLiquidation Voluntary Declaration Of Solvency
2 Dec 2024 Gazette

Gazette Dissolved Liquidation

2 Sept 2024 Insolvency

Liquidation Voluntary Members Return Of Final Meeting

7 Dec 2023 Address

Change Sail Address Company With New Address

15 Nov 2023 Insolvency

Liquidation Voluntary Appointment Of Liquidator

15 Nov 2023 Insolvency

Liquidation Voluntary Declaration Of Solvency

Recent Activity

Latest Activity

Gazette Dissolved Liquidation

1 years ago on 2 Dec 2024

Liquidation Voluntary Members Return Of Final Meeting

1 years ago on 2 Sept 2024

Change Sail Address Company With New Address

2 years ago on 7 Dec 2023

Liquidation Voluntary Appointment Of Liquidator

2 years ago on 15 Nov 2023

Liquidation Voluntary Declaration Of Solvency

2 years ago on 15 Nov 2023